Published in Vaccine Weekly, January 22nd, 2003
"Nonobese diabetic (NOD) mice spontaneously develop diabetes as a consequence of an autoimmune process that can be inhibited by immunotherapy with the 60-kDa heat shock protein, with its mycobacterial counterpart 65-kDa, or with other antigens such as insulin and glutamic acid decarboxylase," explained Francisco J. Quintana and colleagues at the Weizmann Institute of Science in Rehovot, Israel. "In addition to the spontaneous disease, however, NOD mice can develop...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-01-22)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.